NewLink Genetics' Series C Round

NewLink Genetics raised a round of funding on January 18, 2008.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.…

Articles about NewLink Genetics' Series C Round: